A new Covid-19 antiviral pill cuts risk of death by 50 percent. Here’s what you need to know about it
A new way to fight the Covid-19 pandemic is on the horizon. Current treatments are expensive and require patients to be admitted to hospital. But a drug developed by Merck and partner Ridgeback Biotherapeutics is on the cusp of changing…